Want to see IN:NATCOPHARM full AI Analyst Report?

NATCO Pharma Limited (NATCOPHARM) Financial Statements

16 Followers

NATCO Pharma Limited Financial Overview

NATCO Pharma Limited's market cap is currently ₹151.16B. The company's EPS TTM is ₹63.89; its P/E ratio is 12.95; and it has a dividend yield of 0.51%. NATCO Pharma Limited is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₹10.32. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 40.78B	₹ 44.32B	₹ 40.02B	₹ 27.09B	₹ 19.46B
Gross Profit	₹ 33.88B	₹ 37.05B	₹ 32.53B	₹ 20.54B	₹ 13.62B
Operating Income	₹ 12.30B	₹ 30.00B	₹ 25.96B	₹ 14.92B	₹ 6.93B
EBITDA	₹ 17.34B	₹ 21.44B	₹ 17.51B	₹ 9.67B	₹ 2.60B
Net Income	₹ 14.19B	₹ 18.85B	₹ 13.88B	₹ 7.15B	₹ 1.70B
Balance Sheet
Cash & Short-Term Investments	₹ 21.29B	₹ 24.97B	₹ 17.78B	₹ 11.25B	₹ 7.60B
Total Assets	₹ 110.74B	₹ 86.31B	₹ 69.06B	₹ 56.57B	₹ 51.09B
Total Debt	₹ 7.14B	₹ 2.79B	₹ 3.86B	₹ 1.76B	₹ 4.32B
Net Debt	₹ -8.37B	₹ -18.97B	₹ 3.16B	₹ 348.00M	₹ 3.21B
Total Liabilities	₹ 18.53B	₹ 10.19B	₹ 10.53B	₹ -34.80B	₹ 8.46B
Stockholders' Equity	₹ 92.21B	₹ 76.07B	₹ 58.53B	₹ 48.74B	₹ 42.64B
Cash Flow
Free Cash Flow	₹ 13.77B	₹ 14.28B	₹ 8.72B	₹ 6.43B	₹ -1.96B
Operating Cash Flow	₹ 17.68B	₹ 16.97B	₹ 12.12B	₹ 8.49B	₹ 465.00M
Investing Cash Flow	₹ -20.82B	₹ -14.14B	₹ -10.33B	₹ -4.77B	₹ -53.00M
Financing Cash Flow	₹ 2.98B	₹ -2.11B	₹ -2.47B	₹ -3.63B	₹ 348.00M

Currency in INR

NATCO Pharma Limited Earnings and Revenue History

Income Statement >

NATCO Pharma Limited Debt to Assets

Balance Sheet >

NATCO Pharma Limited Cash Flow

Cash Flow >

NATCO Pharma Limited Forecast EPS vs Actual EPS

Earnings >